Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Pre Pregnancy Genetic Testing Market

ID: MRFR/LS/25496-HCR
100 Pages
Rahul Gotadki
Last Updated: April 24, 2026

Pre Pregnancy Genetic Testing Market Research Report By Test Type (Carrier Screening, Preimplantation Genetic Testing (PGT)), By Indication (Age-related, Family History, Genetic Disorders, Unexplained Infertility), By Technology (Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS)), By Service Provider (Hospitals and Clinics, Independent Laboratories, Home Testing Kits), By End User (Individuals, Couples, Healthcare Professionals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Pre Pregnancy Genetic Testing Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Test Type (USD Billion) | |
      1. 4.1.1 Carrier Screening | |
      2. 4.1.2 Preimplantation Genetic Testing (PGT) |
    2. 4.2 Healthcare, BY Indication (USD Billion) | |
      1. 4.2.1 Age-related | |
      2. 4.2.2 Family History | |
      3. 4.2.3 Genetic Disorders | |
      4. 4.2.4 Unexplained Infertility |
    3. 4.3 Healthcare, BY Technology (USD Billion) | |
      1. 4.3.1 Chromosomal Microarray Analysis (CMA) | |
      2. 4.3.2 Next-Generation Sequencing (NGS) |
    4. 4.4 Healthcare, BY Service Provider (USD Billion) | |
      1. 4.4.1 Hospitals and Clinics | |
      2. 4.4.2 Independent Laboratories | |
      3. 4.4.3 Home Testing Kits |
    5. 4.5 Healthcare, BY End User (USD Billion) | |
      1. 4.5.1 Individuals | |
      2. 4.5.2 Couples | |
      3. 4.5.3 Healthcare Professionals |
    6. 4.6 Healthcare, BY Region (USD Billion) | |
      1. 4.6.1 North America | | |
        1. 4.6.1.1 US | | |
        2. 4.6.1.2 Canada | |
      2. 4.6.2 Europe | | |
        1. 4.6.2.1 Germany | | |
        2. 4.6.2.2 UK | | |
        3. 4.6.2.3 France | | |
        4. 4.6.2.4 Russia | | |
        5. 4.6.2.5 Italy | | |
        6. 4.6.2.6 Spain | | |
        7. 4.6.2.7 Rest of Europe | |
      3. 4.6.3 APAC | | |
        1. 4.6.3.1 China | | |
        2. 4.6.3.2 India | | |
        3. 4.6.3.3 Japan | | |
        4. 4.6.3.4 South Korea | | |
        5. 4.6.3.5 Malaysia | | |
        6. 4.6.3.6 Thailand | | |
        7. 4.6.3.7 Indonesia | | |
        8. 4.6.3.8 Rest of APAC | |
      4. 4.6.4 South America | | |
        1. 4.6.4.1 Brazil | | |
        2. 4.6.4.2 Mexico | | |
        3. 4.6.4.3 Argentina | | |
        4. 4.6.4.4 Rest of South America | |
      5. 4.6.5 MEA | | |
        1. 4.6.5.1 GCC Countries | | |
        2. 4.6.5.2 South Africa | | |
        3. 4.6.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Illumina (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Thermo Fisher Scientific (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Myriad Genetics (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Natera (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Fulgent Genetics (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Genomic Health (US) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Invitae (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 GeneDx (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY TEST TYPE |
    7. 6.4 US MARKET ANALYSIS BY INDICATION |
    8. 6.5 US MARKET ANALYSIS BY TECHNOLOGY |
    9. 6.6 US MARKET ANALYSIS BY SERVICE PROVIDER |
    10. 6.7 US MARKET ANALYSIS BY END USER |
    11. 6.8 CANADA MARKET ANALYSIS BY TEST TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY INDICATION |
    13. 6.10 CANADA MARKET ANALYSIS BY TECHNOLOGY |
    14. 6.11 CANADA MARKET ANALYSIS BY SERVICE PROVIDER |
    15. 6.12 CANADA MARKET ANALYSIS BY END USER |
    16. 6.13 EUROPE MARKET ANALYSIS |
    17. 6.14 GERMANY MARKET ANALYSIS BY TEST TYPE |
    18. 6.15 GERMANY MARKET ANALYSIS BY INDICATION |
    19. 6.16 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
    20. 6.17 GERMANY MARKET ANALYSIS BY SERVICE PROVIDER |
    21. 6.18 GERMANY MARKET ANALYSIS BY END USER |
    22. 6.19 UK MARKET ANALYSIS BY TEST TYPE |
    23. 6.20 UK MARKET ANALYSIS BY INDICATION |
    24. 6.21 UK MARKET ANALYSIS BY TECHNOLOGY |
    25. 6.22 UK MARKET ANALYSIS BY SERVICE PROVIDER |
    26. 6.23 UK MARKET ANALYSIS BY END USER |
    27. 6.24 FRANCE MARKET ANALYSIS BY TEST TYPE |
    28. 6.25 FRANCE MARKET ANALYSIS BY INDICATION |
    29. 6.26 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
    30. 6.27 FRANCE MARKET ANALYSIS BY SERVICE PROVIDER |
    31. 6.28 FRANCE MARKET ANALYSIS BY END USER |
    32. 6.29 RUSSIA MARKET ANALYSIS BY TEST TYPE |
    33. 6.30 RUSSIA MARKET ANALYSIS BY INDICATION |
    34. 6.31 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
    35. 6.32 RUSSIA MARKET ANALYSIS BY SERVICE PROVIDER |
    36. 6.33 RUSSIA MARKET ANALYSIS BY END USER |
    37. 6.34 ITALY MARKET ANALYSIS BY TEST TYPE |
    38. 6.35 ITALY MARKET ANALYSIS BY INDICATION |
    39. 6.36 ITALY MARKET ANALYSIS BY TECHNOLOGY |
    40. 6.37 ITALY MARKET ANALYSIS BY SERVICE PROVIDER |
    41. 6.38 ITALY MARKET ANALYSIS BY END USER |
    42. 6.39 SPAIN MARKET ANALYSIS BY TEST TYPE |
    43. 6.40 SPAIN MARKET ANALYSIS BY INDICATION |
    44. 6.41 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
    45. 6.42 SPAIN MARKET ANALYSIS BY SERVICE PROVIDER |
    46. 6.43 SPAIN MARKET ANALYSIS BY END USER |
    47. 6.44 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE |
    48. 6.45 REST OF EUROPE MARKET ANALYSIS BY INDICATION |
    49. 6.46 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
    50. 6.47 REST OF EUROPE MARKET ANALYSIS BY SERVICE PROVIDER |
    51. 6.48 REST OF EUROPE MARKET ANALYSIS BY END USER |
    52. 6.49 APAC MARKET ANALYSIS |
    53. 6.50 CHINA MARKET ANALYSIS BY TEST TYPE |
    54. 6.51 CHINA MARKET ANALYSIS BY INDICATION |
    55. 6.52 CHINA MARKET ANALYSIS BY TECHNOLOGY |
    56. 6.53 CHINA MARKET ANALYSIS BY SERVICE PROVIDER |
    57. 6.54 CHINA MARKET ANALYSIS BY END USER |
    58. 6.55 INDIA MARKET ANALYSIS BY TEST TYPE |
    59. 6.56 INDIA MARKET ANALYSIS BY INDICATION |
    60. 6.57 INDIA MARKET ANALYSIS BY TECHNOLOGY |
    61. 6.58 INDIA MARKET ANALYSIS BY SERVICE PROVIDER |
    62. 6.59 INDIA MARKET ANALYSIS BY END USER |
    63. 6.60 JAPAN MARKET ANALYSIS BY TEST TYPE |
    64. 6.61 JAPAN MARKET ANALYSIS BY INDICATION |
    65. 6.62 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
    66. 6.63 JAPAN MARKET ANALYSIS BY SERVICE PROVIDER |
    67. 6.64 JAPAN MARKET ANALYSIS BY END USER |
    68. 6.65 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE |
    69. 6.66 SOUTH KOREA MARKET ANALYSIS BY INDICATION |
    70. 6.67 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
    71. 6.68 SOUTH KOREA MARKET ANALYSIS BY SERVICE PROVIDER |
    72. 6.69 SOUTH KOREA MARKET ANALYSIS BY END USER |
    73. 6.70 MALAYSIA MARKET ANALYSIS BY TEST TYPE |
    74. 6.71 MALAYSIA MARKET ANALYSIS BY INDICATION |
    75. 6.72 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
    76. 6.73 MALAYSIA MARKET ANALYSIS BY SERVICE PROVIDER |
    77. 6.74 MALAYSIA MARKET ANALYSIS BY END USER |
    78. 6.75 THAILAND MARKET ANALYSIS BY TEST TYPE |
    79. 6.76 THAILAND MARKET ANALYSIS BY INDICATION |
    80. 6.77 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
    81. 6.78 THAILAND MARKET ANALYSIS BY SERVICE PROVIDER |
    82. 6.79 THAILAND MARKET ANALYSIS BY END USER |
    83. 6.80 INDONESIA MARKET ANALYSIS BY TEST TYPE |
    84. 6.81 INDONESIA MARKET ANALYSIS BY INDICATION |
    85. 6.82 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
    86. 6.83 INDONESIA MARKET ANALYSIS BY SERVICE PROVIDER |
    87. 6.84 INDONESIA MARKET ANALYSIS BY END USER |
    88. 6.85 REST OF APAC MARKET ANALYSIS BY TEST TYPE |
    89. 6.86 REST OF APAC MARKET ANALYSIS BY INDICATION |
    90. 6.87 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
    91. 6.88 REST OF APAC MARKET ANALYSIS BY SERVICE PROVIDER |
    92. 6.89 REST OF APAC MARKET ANALYSIS BY END USER |
    93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
    94. 6.91 BRAZIL MARKET ANALYSIS BY TEST TYPE |
    95. 6.92 BRAZIL MARKET ANALYSIS BY INDICATION |
    96. 6.93 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
    97. 6.94 BRAZIL MARKET ANALYSIS BY SERVICE PROVIDER |
    98. 6.95 BRAZIL MARKET ANALYSIS BY END USER |
    99. 6.96 MEXICO MARKET ANALYSIS BY TEST TYPE |
    100. 6.97 MEXICO MARKET ANALYSIS BY INDICATION |
    101. 6.98 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
    102. 6.99 MEXICO MARKET ANALYSIS BY SERVICE PROVIDER |
    103. 6.100 MEXICO MARKET ANALYSIS BY END USER |
    104. 6.101 ARGENTINA MARKET ANALYSIS BY TEST TYPE |
    105. 6.102 ARGENTINA MARKET ANALYSIS BY INDICATION |
    106. 6.103 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
    107. 6.104 ARGENTINA MARKET ANALYSIS BY SERVICE PROVIDER |
    108. 6.105 ARGENTINA MARKET ANALYSIS BY END USER |
    109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE |
    110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY INDICATION |
    111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
    112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE PROVIDER |
    113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
    114. 6.111 MEA MARKET ANALYSIS |
    115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE |
    116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY INDICATION |
    117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
    118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SERVICE PROVIDER |
    119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY END USER |
    120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE |
    121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY INDICATION |
    122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
    123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SERVICE PROVIDER |
    124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY END USER |
    125. 6.122 REST OF MEA MARKET ANALYSIS BY TEST TYPE |
    126. 6.123 REST OF MEA MARKET ANALYSIS BY INDICATION |
    127. 6.124 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
    128. 6.125 REST OF MEA MARKET ANALYSIS BY SERVICE PROVIDER |
    129. 6.126 REST OF MEA MARKET ANALYSIS BY END USER |
    130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
    131. 6.128 RESEARCH PROCESS OF MRFR |
    132. 6.129 DRO ANALYSIS OF HEALTHCARE |
    133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
    136. 6.133 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE) |
    137. 6.134 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion) |
    138. 6.135 HEALTHCARE, BY INDICATION, 2024 (% SHARE) |
    139. 6.136 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Billion) |
    140. 6.137 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
    141. 6.138 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
    142. 6.139 HEALTHCARE, BY SERVICE PROVIDER, 2024 (% SHARE) |
    143. 6.140 HEALTHCARE, BY SERVICE PROVIDER, 2024 TO 2035 (USD Billion) |
    144. 6.141 HEALTHCARE, BY END USER, 2024 (% SHARE) |
    145. 6.142 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
    146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    147. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.2.5 BY END USER, 2025-2035 (USD Billion) |
    149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.3.5 BY END USER, 2025-2035 (USD Billion) |
    150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.4.5 BY END USER, 2025-2035 (USD Billion) |
    151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.5.5 BY END USER, 2025-2035 (USD Billion) |
    152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.6.5 BY END USER, 2025-2035 (USD Billion) |
    153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.7.5 BY END USER, 2025-2035 (USD Billion) |
    154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.8.5 BY END USER, 2025-2035 (USD Billion) |
    155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.9.5 BY END USER, 2025-2035 (USD Billion) |
    156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.10.5 BY END USER, 2025-2035 (USD Billion) |
    157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.11.5 BY END USER, 2025-2035 (USD Billion) |
    158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.12.5 BY END USER, 2025-2035 (USD Billion) |
    159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.13.5 BY END USER, 2025-2035 (USD Billion) |
    160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.14.5 BY END USER, 2025-2035 (USD Billion) |
    161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.15.5 BY END USER, 2025-2035 (USD Billion) |
    162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.16.5 BY END USER, 2025-2035 (USD Billion) |
    163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.17.5 BY END USER, 2025-2035 (USD Billion) |
    164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.18.5 BY END USER, 2025-2035 (USD Billion) |
    165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.19.5 BY END USER, 2025-2035 (USD Billion) |
    166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.20.5 BY END USER, 2025-2035 (USD Billion) |
    167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.21.5 BY END USER, 2025-2035 (USD Billion) |
    168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.22.5 BY END USER, 2025-2035 (USD Billion) |
    169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.23.5 BY END USER, 2025-2035 (USD Billion) |
    170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.24.5 BY END USER, 2025-2035 (USD Billion) |
    171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.25.5 BY END USER, 2025-2035 (USD Billion) |
    172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.26.5 BY END USER, 2025-2035 (USD Billion) |
    173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.27.5 BY END USER, 2025-2035 (USD Billion) |
    174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.28.5 BY END USER, 2025-2035 (USD Billion) |
    175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.29.5 BY END USER, 2025-2035 (USD Billion) |
    176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY TEST TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY INDICATION, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY SERVICE PROVIDER, 2025-2035 (USD Billion) | |
      5. 7.30.5 BY END USER, 2025-2035 (USD Billion) |
    177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    178. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Test Type (USD Billion, 2025-2035)

  • Carrier Screening
  • Preimplantation Genetic Testing (PGT)

Healthcare By Indication (USD Billion, 2025-2035)

  • Age-related
  • Family History
  • Genetic Disorders
  • Unexplained Infertility

Healthcare By Technology (USD Billion, 2025-2035)

  • Chromosomal Microarray Analysis (CMA)
  • Next-Generation Sequencing (NGS)

Healthcare By Service Provider (USD Billion, 2025-2035)

  • Hospitals and Clinics
  • Independent Laboratories
  • Home Testing Kits

Healthcare By End User (USD Billion, 2025-2035)

  • Individuals
  • Couples
  • Healthcare Professionals

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions